News: Report Says Indian Biopharmas Lack as Innovation Partners

According to a report by the Boston Consulting Group, India's biopharmaceutical manufacturers, while performing relatively well in the minds of global biopharma executives, are still viewed as lacking in innovation. In addition, the report states that India still accounts for just roughly one percent of oversees R&D investment by U.S. biopharma companies.

Read on for BCG summary of the report, and for the news item in the Hindu Business Line.

More News:

All news »

What are your comments?

You cannot post comments until you have logged in. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments